UPDATE: Danaher Buying Beckman Coulter for $6.8B

Today's announcement ends two months of speculation about the future of Beckman Coulter as Danaher continues to add to its life sciences tools portfolio.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories